MAPT and Alzheimer disease: Given that abnormal tau accumulation is generally initiated by its hyperphosphorylation,9 we developed in the present study a novel tau-based therapeutic tool by specifically facilitating tau dephosphorylation at the post-translational level, which might provide an early-stage treatment of AD and related tauopathies before the onset of abnormal tau accumulation.